Chemerin triggers migration of a CD8 T cell subset with natural killer cell functions.
CMKLR1
T cell trafficking
chemerin
chemoattractant
immune oncology
integrin
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581
Informations de publication
Date de publication:
04 Oct 2023
04 Oct 2023
Historique:
received:
05
04
2023
revised:
31
07
2023
accepted:
25
08
2023
pmc-release:
04
10
2024
pubmed:
29
8
2023
medline:
29
8
2023
entrez:
29
8
2023
Statut:
ppublish
Résumé
The recruitment of cells with effector functions into the tumor microenvironment holds potential for delaying cancer progression. We show that subsets of human CD28-effector CD8 T cells, CCR7
Identifiants
pubmed: 37641406
pii: S1525-0016(23)00447-1
doi: 10.1016/j.ymthe.2023.08.015
pmc: PMC10556222
mid: NIHMS1932080
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2887-2900Subventions
Organisme : BLRD VA
ID : I01 BX004115
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.
Références
JCI Insight. 2021 Nov 8;6(21):
pubmed: 34609965
Front Immunol. 2017 Jan 23;8:31
pubmed: 28167946
J Dev Orig Health Dis. 2022 Feb;13(1):108-114
pubmed: 33781365
Nat Immunol. 2020 Jun;21(6):684-694
pubmed: 32231301
Oncogene. 2017 Jun 22;36(25):3541-3552
pubmed: 28114280
J Biol Chem. 2011 Nov 11;286(45):39510-9
pubmed: 21949124
Cancers (Basel). 2022 Jun 28;14(13):
pubmed: 35804934
J Biol Chem. 2003 Oct 3;278(40):38174-82
pubmed: 12844491
Cell. 2018 Apr 5;173(2):291-304.e6
pubmed: 29625048
Cell. 2017 Jun 15;169(7):1342-1356.e16
pubmed: 28622514
J Biol Chem. 2004 Mar 12;279(11):9956-62
pubmed: 14701797
Sci Rep. 2020 Aug 13;10(1):13702
pubmed: 32792625
Front Immunol. 2018 Nov 30;9:2772
pubmed: 30555465
Int J Mol Sci. 2020 Oct 05;21(19):
pubmed: 33027962
Cell. 2021 Aug 19;184(17):4512-4530.e22
pubmed: 34343496
Int J Mol Sci. 2019 Jun 08;20(11):
pubmed: 31181772
Cell. 2018 Dec 13;175(7):1731-1743.e13
pubmed: 30503213
Am J Clin Exp Immunol. 2014 Feb 27;3(1):1-19
pubmed: 24660117
Exp Physiol. 2019 Jan;104(1):93-99
pubmed: 30565770
J Immunol. 2010 Apr 1;184(7):3461-9
pubmed: 20194717
Cell. 2018 Jul 26;174(3):716-729.e27
pubmed: 29961576
Clin Exp Immunol. 1995 Jun;100(3):425-33
pubmed: 7539725
EMBO Mol Med. 2017 Sep;9(9):1183-1197
pubmed: 28765140
Cell Immunol. 2009;254(2):149-54
pubmed: 18835598
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
J Leukoc Biol. 2008 Dec;84(6):1530-8
pubmed: 18753310
J Immunol. 2009 Nov 15;183(10):6717-23
pubmed: 19864606
Sci Transl Med. 2020 Apr 1;12(537):
pubmed: 32238575
J Exp Med. 2012 Jul 30;209(8):1427-35
pubmed: 22753924
Nat Med. 2018 Jul;24(7):978-985
pubmed: 29942094
Genome Biol. 2016 Apr 27;17:75
pubmed: 27122128
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Front Immunol. 2019 May 08;10:983
pubmed: 31139180
J Exp Med. 2000 Jul 3;192(1):63-75
pubmed: 10880527
Nat Commun. 2020 Jul 30;11(1):3798
pubmed: 32732867
P T. 2011 Apr;36(4):197-202
pubmed: 21572775
J Immunol. 2010 Sep 15;185(6):3728-39
pubmed: 20720202
Science. 1998 Jan 16;279(5349):381-4
pubmed: 9430588
Immunol Rev. 2002 Oct;188:33-42
pubmed: 12445279
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Acta Biochim Pol. 2009;56(2):355-60
pubmed: 19543554
Exp Hematol. 2006 Aug;34(8):1106-14
pubmed: 16863918
J Immunol. 2005 Jan 1;174(1):244-51
pubmed: 15611246